CSF1R Blockade for Refractory Chronic Graft-versus-Host Disease

被引：3
|
作者：
Mohty, Mohamad [1 ,2 ]
机构：
[1] Sorbonne Univ, Hop St Antoine, Ctr Rech St Antoine, Serv Hematol Clin & Therapie Cellulaire, Paris, France
[2] Hop St Antoine, AP HP, Serv Hematol Clin & Therapie Cellulaire, Paris, France
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2024年 / 391卷 / 11期
关键词：
D O I：
10.1056/NEJMe2407369
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1055 / 1059
页数：5
相关论文
共 50 条
  • [31] Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft-versus-host disease
    Hurabielle, C.
    de Fontbrune, F. Sicre
    Moins-Teisserenc, H.
    Robin, M.
    Jachiet, M.
    Coman, T.
    Dhedin, N.
    Cassius, C.
    Chasset, F.
    de Masson, A.
    Michonneau, D.
    Bagot, M.
    Bergeron, A.
    Socie, G.
    de Latour, R. Peffault
    Bouaziz, J-D
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E206 - E208
  • [32] Infliximab for treatment of steroid refractory acute and chronic graft-versus-host disease
    Trenschel, R
    Trampenau, C
    Ditschkowski, M
    Elmaagacli, A
    Ottinger, H
    Steckel, N
    Biersack, H
    Peceny, R
    Beelen, D
    BONE MARROW TRANSPLANTATION, 2003, 31 : S128 - S129
  • [33] Topical sirolimus for management of refractory oral chronic graft-versus-host disease
    Treister, Nathaniel
    Li, Shuli
    Soiffer, Robert
    Cutler, Corey
    ORAL DISEASES, 2021, 27 (06) : 1451 - 1454
  • [34] URSODEOXYCHOLIC ACID TREATMENT OF REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE OF THE LIVER
    FRIED, RH
    MURAKAMI, CS
    FISHER, LD
    WILLSON, RA
    SULLIVAN, KM
    MCDONALD, GB
    ANNALS OF INTERNAL MEDICINE, 1992, 116 (08) : 624 - 629
  • [35] Topical cyclosporine for treatment of refractory ocular chronic graft-versus-host disease
    Rzepecki, P
    Sarosiek, T
    Langiewicz, P
    Zolnierek, J
    Szczylik, C
    BONE MARROW TRANSPLANTATION, 2006, 37 : S96 - S96
  • [36] Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease
    Rubegni, P
    Cuccia, A
    Sbano, P
    Cevenini, G
    Carcagnì, MR
    D'Ascenzo, G
    De Aloe, G
    Guidi, S
    Guglielmetti, P
    Marotta, G
    Lauria, F
    Bosi, A
    Fimiani, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (02) : 271 - 275
  • [37] Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease
    Jurado, Manuel
    Vallejo, Carlos
    Perez-Simon, Jose A.
    Brunet, Salut
    Ferra, Christelle
    Balsalobre, Pascual
    Perez-Oteyza, Jaime
    Espigado, Ildefonso
    Romero, Antonio
    Caballero, Dolores
    Sierra, Jorge
    Ribera, Jose M.
    Diez, Jose L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (06) : 701 - 706
  • [38] Response to mycophenolate mofetil therapy for refractory chronic graft-versus-host disease
    Busca, A
    Locatelli, F
    Marmont, F
    Audisio, E
    Falda, M
    HAEMATOLOGICA, 2003, 88 (07) : 837 - 838
  • [39] Promising efficacy of Ibrutinib in the treatment of Chronic refractory graft-versus-host disease
    Stocker, Nicolas
    HEMATOLOGIE, 2018, 24 (01): : 21 - 22
  • [40] Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab
    Willenbacher, W
    Basara, N
    Blau, IW
    Fauser, AA
    Kiehl, MG
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) : 820 - 823
12345